SEC Form 4 · accession 0001437749-18-017487
Proto Labs Inc · PRLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Way
Officer — Chief Financial Officer
Period of report
Sep 24, 2018
Accepted (ET)
Sep 26, 2018 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001443669
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 24, 2018 | M | 5,000 | $67.15 | A | 30,503 | D | |
| Common Stock | Sep 24, 2018 | M | 3,000 | $57.88 | A | 33,503 | D | |
| Common StockF3 | Sep 24, 2018 | S | 3,356 | $157.6593 | D | 30,147 | D | |
| Common StockF4 | Sep 24, 2018 | S | 4,644 | $160.1403 | D | 25,503 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F5 | $67.15 | Sep 24, 2018 | M | 5,000 | D | — | Feb 9, 2025 | Common Stock | 5,000 | 4,995 | D |
| Employee Stock Option (right to buy)F6 | $57.88 | Sep 24, 2018 | M | 3,000 | D | — | Feb 8, 2026 | Common Stock | 3,000 | 11,185 | D |
Explanation of responses
- F1Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan.
- F2Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan.
- F3Reflects the weighted average price of 3,356 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 24, 2018 with sale prices ranging from $157.50 to $158.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average price of 4,444 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 24, 2018 with sale prices ranging from $160.00 to $160.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016.
- F6The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017.